Using telehealth to improve care for nursing home residents with Alzheimer's disease
Official title: Telehealth Use in Nursing Homes and the Quality of Care for Long-Stay Residents with Alzheimer's Disease and Related Dementias
Funded at Weill Medical Coll of Cornell Univ · NIH-10984740 · Data updated 2026-11-12
This study is looking at how using telehealth services can make life better for nursing home residents with Alzheimer's and related dementias by improving their access to doctors and care, especially during the COVID-19 pandemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $2,373,964 |
| NIH project number | 1RF1AG089362-01 |
| Project ID | NIH-10984740 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are nursing home residents aged 85 and older who are diagnosed with Alzheimer's disease or related dementias.
✕Less likely to help
Patients who do not reside in nursing homes or those without a diagnosis of Alzheimer's disease or related dementias may not benefit from this research.
What this research studies
This research investigates how telehealth services can enhance the quality of care for long-stay residents in nursing homes who have Alzheimer's disease and related dementias. By analyzing the impact of expanded telehealth coverage during the COVID-19 pandemic, the study aims to identify how these services can improve access to specialty care and overall patient outcomes. The approach includes evaluating the effectiveness of telehealth in facilitating communication among residents, caregivers, and healthcare providers, as well as its potential to reduce hospitalizations. The research will also explore any challenges or unintended consequences of telehealth use in this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved access to timely and effective healthcare for nursing home residents with Alzheimer's disease.
How similar studies have gone: Previous research has shown promising results in using telehealth to improve care access and quality for similar populations, indicating that this approach has potential for success.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Jung, Hye-Young — Weill Medical Coll of Cornell Univ
- Study coordinator: Jung, Hye-Young
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.